Rafael Correra

Company: ThyTech

Job title: Chief Scientific Officer

Seminars:

Keynote Presentation: Alternative Treg Sources: Inducing Immune Tolerance with thyTregs™: A Highly Pure & Stable Treg Population Derived from Thymic Tissue 9:30 am

Unveiling thyTregs™ as a best-in-class allogeneic Treg therapy platform Reviewing thyTreg™ allogeneic product scale-up Showcasing the clinical development of a thyTreg™ candidate for tolerance induction and autoimmunitiesRead more

day: Conference Day One AM